摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-isopropyl-2,2-dimethyl-2H,4H-1,3-dioxin-4-one | 95410-27-8

中文名称
——
中文别名
——
英文名称
6-isopropyl-2,2-dimethyl-2H,4H-1,3-dioxin-4-one
英文别名
2,2-dimethyl-6-isopropyl-1,3-dioxin-4-one;2,2-dimethyl-6-isopropyl-4H-1,3-dioxin-4-one;6-(2-propyl)-2,2-dimethyl-2H,4H-1,3-dioxin-4-one;2,2-Dimethyl-6-propan-2-yl-1,3-dioxin-4-one
6-isopropyl-2,2-dimethyl-2H,4H-1,3-dioxin-4-one化学式
CAS
95410-27-8
化学式
C9H14O3
mdl
——
分子量
170.208
InChiKey
NSPBGAFODJIVJI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    6-isopropyl-2,2-dimethyl-2H,4H-1,3-dioxin-4-one 作用下, 以 xylene 为溶剂, 生成 4-methyl-3-oxopentanamide
    参考文献:
    名称:
    Sato, Masayuki; Ogasawara, Hiromichi; Komatsu, Sachiko, Chemical and pharmaceutical bulletin, 1984, vol. 32, # 10, p. 3848 - 3856
    摘要:
    DOI:
  • 作为产物:
    描述:
    丙二酸环(亚)异丙酯吡啶 作用下, 以 二氯甲烷丙酮甲苯 为溶剂, 反应 3.17h, 生成 6-isopropyl-2,2-dimethyl-2H,4H-1,3-dioxin-4-one
    参考文献:
    名称:
    Creation through Immobilization: A New Family of High Performance Heterogeneous Bifunctional Iminophosphorane (BIMP) Superbase Organocatalysts
    摘要:
    An immobilized chiral bifunctional iminophosphorane superbase organocatalyst has been developed and applied in a range of challenging enantioselective reactions. A unique feature of this novel catalytic system is that the final step creation of the iminophosphorane occurs at the point of immobilization. The utility of the immobilized catalyst system was demonstrated in the nitro-Mannich reaction of ketimines as well as the conjugate addition of high pK(a) 1,3-dicarbonyl pro-nucleophiles to nitrostyrene. Catalyst recycling was also demonstrated.
    DOI:
    10.1021/ol5029942
点击查看最新优质反应信息

文献信息

  • Dihydropyridines and new uses thereof
    申请人:Synaptic Pharmaceutical Corporation
    公开号:US05767131A1
    公开(公告)日:1998-06-16
    The invention provides a method of treating benign prostatic hyperplasia in a subject which comprises administering to the subject a therapeutically effective amount of a compound having the structure: ##STR1## wherein Y is --(CH.sub.2).sub.n --, where n is 1, 2, 3, 4 or 5; --(CH.sub.2).sub.h --O--(CH.sub.2).sub.k --, where h and k are independently the same or different and are 2, 3 or 4; --(CH.sub.2).sub.h --CH.dbd.CH--(CH.sub.2).sub.k --; or --(CH.sub.2).sub.h --C.tbd.C--(CH.sub.2).sub.k --, where h and k are independently the same or different and are 1, 2, 3 or 4; wherein Z is O, NH, or CH.sub.2 ; wherein R.sup.1 is a linear or branched chain alkyl, alkoxyalkyl or arylalkyl group; wherein R.sup.2 and R.sup.4 are independently the same or different and are H, or a linear or branched chain alkyl group; wherein R.sup.3 is H, a linear or branched chain alkyl, alkoxy, alkoxyalkyl or acyl group; and wherein R.sup.5 and R.sup.6 are independently the same or different and are H, OH, Cl, Br, F, NO.sub.2, CN, CF.sub.3, or NH.sub.2, or a linear or branched chain alkyl, alkoxy, alkoxycarbonyl, acyl, alkylsulfoxide, alkylsulfone, or mono- or dialkylamino group. Other active compounds containing one, two or three rings are also disclosed as well as pharmaceutical compositions prepared therefrom and methods of use in the treatment of BPH, inhibition of cholesterol synthesis, and reduction of intraocular pressure.
    该发明提供了一种治疗良性前列腺增生的方法,包括向受试者施用具有以下结构的化合物的治疗有效量: 其中Y为--(CH.sub.2).sub.n --,其中n为1、2、3、4或5;--(CH.sub.2).sub.h --O--(CH.sub.2).sub.k --,其中h和k独立且相同或不同,为2、3或4;--(CH.sub.2).sub.h --CH.dbd.CH--(CH.sub.2).sub.k --;或--(CH.sub.2).sub.h --C.tbd.C--(CH.sub.2).sub.k --,其中h和k独立且相同或不同,为1、2、3或4;其中Z为O、NH或CH.sub.2;其中R.sup.1为线性或支链烷基、烷氧基烷基或芳基烷基;其中R.sup.2和R.sup.4独立且相同或不同,为H,或线性或支链烷基;其中R.sup.3为H、线性或支链烷基、烷氧基、烷氧基烷基或酰基;其中R.sup.5和R.sup.6独立且相同或不同,为H、OH、Cl、Br、F、NO.sub.2、CN、CF.sub.3或NH.sub.2,或线性或支链烷基、烷氧基、烷氧羰基、酰基、烷基亚砜、烷基砜、或单烷基或二烷基氨基基团。还公开了含有一、两个或三个环的其他活性化合物,以及由此制备的药物组合物和在治疗BPH、抑制胆固醇合成和降低眼压中的使用方法。
  • A convenient synthesis of unsymmetrical, substituted γ-pyrones from Meldrum's acid
    作者:Frank J. Zawacki、Michael T. Crimmins
    DOI:10.1016/0040-4039(96)01470-0
    日期:1996.9
    A unique approach to the synthesis of mono and disubstituted γ-pyrones from acylated Meldrum's acid and vinyl ethers has been developed. The convenient one pot synthesis of these versatile polyketide equivalents is accomplished without strong base or low temperatures.
    从酰化的麦德鲁姆酸和乙烯基醚合成单和双取代的γ-吡喃酮的独特方法已经开发出来。这些通用的聚酮化合物等效物的便捷一锅合成无需强碱或低温即可完成。
  • Regioselective Oxygenations of <i>S</i>-<i>Trans</i> Dienes, Silyl Dienol Ethers (SDEs), by Triphenyl Phosphite Ozonide (TPPO) and Its Mechanistic Study
    作者:Atsushi Mori、Manabu Abe、Masatomo Nojima
    DOI:10.1021/jo015562v
    日期:2001.5.1
    The direct oxygenation of s-trans dienes, silyl dienol ethers (SDEs) 2, by triphenyl phosphite ozonide (TPPO) has been examined in detail. The regioselective oxygenation was found to give hydroperoxide 3, alcohol 4, ketone 5, dimer 6, and peroxy phosphate 7 with concomitant formation of triphenyl phosphate 8 and diphenyl trimethylsilyl phosphate 10. The formation of peroxy phosphate 7 was found for
    已详细研究了亚磷酸三苯酯(TPPO)对s-反式二烯,甲硅烷基二烯醚(SDEs)2的直接氧化。发现区域选择性氧化产生氢过氧化物3,醇4,酮5,二聚体6和过氧磷酸盐7,同时形成磷酸三苯酯8和二苯基三甲基甲硅烷基磷酸酯10。在TPPO中首次发现过氧磷酸酯7的形成。氧化反应。低温(31)P和(1)H NMR光谱分析证明SDE与TPPO的直接反应而不会产生单线态氧。通过两性离子ZI的干预可以合理地解释含氧产物3-7的形成,该两性离子ZI可以通过SDE对臭氧化物的中心氧的亲核攻击而形成。
  • 一种1,4-二氢吡啶类双官能手性催化剂及其制备方法和应用
    申请人:广西九圣新材料有限公司
    公开号:CN109824652A
    公开(公告)日:2019-05-31
    本发明属于有机催化领域,公开了一种新型1,4‑二氢吡啶类双官能手性催化剂及其制备方法和应用。所述手性催化剂的化学结构通式如式(I)所示:本发明是以1,4‑二氢吡啶衍生物和手性四氢吡咯衍生物为原料,最终合成出一种新型1,4‑二氢吡啶类双官能手性催化剂,该方法的合成反应条件温和,产率高,操作步骤简单,安全可靠,绿色环保,所述催化剂可应用在不对称催化转移氢化、手性精细化学品合成、手性药物或药物中间体合成、手性新材料、手性功能分子合成等领域中,应用前景广泛。
  • Total Synthesis of (−)-Rhizopodin
    作者:Stephen M. Dalby、Jake Goodwin-Tindall、Ian Paterson
    DOI:10.1002/anie.201301978
    日期:2013.6.17
    Core assembly: The total synthesis of the myxobacterial metabolite rhizopodin, a potent actin‐binding anticancer agent, has been achieved. The modular synthesis utilizes a common C1–C22 monomeric unit to assemble the dimeric 38‐membered macrodiolide core, which was elaborated by a bidirectional boron‐mediated aldol reaction to install the characteristic side‐chains. The final global deprotection was
    核心组装:已经完成了一种强效的肌动蛋白结合抗癌药,即粘细菌代谢产物根瘤菌素的全合成。模块化合成利用一个常见的C1-C22单体单元组装二聚体38元大分子二醇核,这是通过双向硼介导的羟醛缩合反应进行了详细说明,以安装特征性的侧链。最终的整体脱保护主要取决于C16 / C16'处甲硅烷基保护基的正确选择。
查看更多